Results 11 to 20 of about 3,365,654 (307)
Sarcopenia and Sarcopenic Obesity in Postmenopausal Women: Limitations of BMI as a Predictor of Sarcopenic Obesity. [PDF]
Aging Med (Milton)The prevalence of sarcopenia and sarcopenic obesity is large among community‐dwelling postmenopausal women, and lower body mass index is a significant predictor of both. The finding that low body mass index predicts both sarcopenia and sarcopenic obesity, highlights the limitation of body mass index as a measure of adiposity in the assessment of ...
Rajan R +7 more
europepmc +2 more sources
Hormone replacement therapy is associated with improved verbal declarative memory in healthy relatively recent postmenopausal women. [PDF]
, 2006 The efficacy of Hormone Replacement Therapy (HRT) for cognitive health in postmenopausal women has been systematically questioned during the last decade.
Sünram-Lea, Sandra I., Papavasiliou, E.
core +5 more sources
Osteoporosis in postmenopausal women
Canadian Family Physician, 2021 How effective are bisphosphonates and denosumab for preventing fractures in postmenopausal women? Bisphosphonates and denosumab are similarly effective. Over 1 to 4 years, bisphosphonates or denosumab provide an absolute reduction of about 0.5% to 1.0% for hip fractures, 1.5% to 3 ...
Samantha, Moe +2 more
openaire +2 more sources
Postmenopausal women in gynecological care [PDF]
Menopausal Review, 2021 Menopause is one of the most important events in the female reproductive life cycle, being a transition from the reproductive to the nonreproductive stage. It is a milestone that may have a negative influence on quality of life and one that brings in several physiological changes that affect the life of a woman permanently.
Magdalena Pertyńska-Marczewska +1 more
openaire +3 more sources
Hypertension in Postmenopausal Women [PDF]
Current Hypertension Reports, 2012 Blood pressure is typically lower in premenopausal women than in men. However, after menopause, the prevalence of hypertension in women is higher than it is in men. Hypertension is a major risk factor for cardiovascular disease in women and men, but cardiovascular disease is the leading cause of death in women. Furthermore, there is evidence that blood
Roberta, Lima +2 more
openaire +2 more sources
Effect of anastrozole on bone mineral density and lipid profiles when used to prevent breast cancer in high risk postmenopausal women [PDF]
, 2012 PhDThe role of aromatase inhibitors (AIs) in breast cancer has expanded since their introduction in the mid-1990s. They are superior to tamoxifen in the treatment of postmenopausal women with oestrogen dependant tumours in the metastatic, neoadjuvant ...
Singh, Shalini
core +4 more sources
Risk factors for osteoporosis in South Asian and Caucasian postmenopausal women [PDF]
, 2011 There is evidence to show that the risk of osteoporosis is greater for South Asian females compared to Caucasian females. This is due to differences in bone mineral density and other risk factors which contribute to this condition such as calcium and ...
Gifford, Heather
core +2 more sources
Androgen in postmenopausal women
The Journal of Medical Investigation, 2012 Menopausal symptoms, bone loss, changes in lipid profiles and reduction of insulin sensitivity due to an abrupt decrease in circulating estrogen level are well known in women during the menopausal transition. On the other hand, the effect of androgen on women's health has not been fully elucidated.
Yasui, Toshiyuki +5 more
openaire +3 more sources
Preventative therapies for healthy women at high risk of breast cancer [PDF]
, 2014 Ivana Sestak Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Charterhouse Square, London, UKAbstract: Tamoxifen has been shown to reduce the risk of developing estrogen receptor (ER)-positive ...
Sestak I, Sestak, I
core +1 more source
Hormone therapy for postmenopausal women [PDF]
REPRODUCTIVE ENDOCRINOLOGY, 2020 Hormone therapy is recommended for relief from hot flashes or night sweats in women younger than age 60 years or those who entered menopause within 10 years of seeking treatment. Hormone therapy also can reduce bone loss and the risk of fractures; offer a potential cardioprotective benefit; and alleviate the genitourinary symptoms of menopause ...
openaire +6 more sources